valinol has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
*Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katzhendler, J; Khamaisie, H; Khatib, S; Mahajna, J; Najajreh, Y; Ruimi, N; Ruthardt, M | 1 |
1 other study(ies) available for valinol and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Oleylamine-carbonyl-valinol inhibits auto-phosphorylation activity of native and T315I mutated Bcr-Abl, and exhibits selectivity towards oncogenic Bcr-Abl in SupB15 ALL cell lines.
Topics: Amines; Cell Line, Tumor; Dose-Response Relationship, Drug; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Protein Kinase Inhibitors; Tumor Stem Cell Assay; Valine | 2013 |